PROPANC BIOPHARMA, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PROPANC BIOPHARMA, INC. stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $7.50K, a 99.99% decline year-over-year.
- PROPANC BIOPHARMA, INC. stock issued during period, value, issued for services for the quarter ending 2025-12-31 was $7.50K.
- PROPANC BIOPHARMA, INC. stock issued during period, value, issued for services for the quarter ending 2025-03-31 was $51.33M.
- PROPANC BIOPHARMA, INC. stock issued during period, value, issued for services for the quarter ending 2024-09-30 was $15.00K.
- PROPANC BIOPHARMA, INC. stock issued during period, value, issued for services for fiscal 2023 was $138.95K.
- PROPANC BIOPHARMA, INC. stock issued during period, value, issued for services for fiscal 2021 was $125.57K, a 10.50% increase from fiscal 2020.
- PROPANC BIOPHARMA, INC. stock issued during period, value, issued for services for fiscal 2020 was $113.64K, a 32.76% decline from fiscal 2019.
- PROPANC BIOPHARMA, INC. stock issued during period, value, issued for services for fiscal 2019 was $169.00K, a 30.00% increase from fiscal 2018.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-03-31 | $7.50K S-1 · filed 2026-07-17 | |
| 2025-12-31 | $7.50K S-1 · filed 2026-07-17 | |
| 2025-06-30 | $23.88M S-1 · filed 2026-07-17 | |
| 2025-03-31 | $51.33M S-1 · filed 2026-07-17 | |
| 2024-09-30 | $15.00K S-1 · filed 2026-07-17 | |
| 2023-06-30 | $138.95K 10-K · filed 2024-09-30 | |
| 2022-12-31 | $56.81K 10-Q · filed 2024-05-15 | |
| 2022-03-31 | $89.03K 10-Q · filed 2023-05-15 | |
| 2021-09-30 | $581.86K 10-Q · filed 2022-05-16 | |
| 2021-06-30 | $125.57K 10-K · filed 2022-09-28 | |
| 2021-03-31 | $67.51K 10-Q · filed 2022-05-16 | |
| 2020-06-30 | $113.64K 10-K · filed 2021-09-28 | |
| 2020-03-31 | $21.00K 10-Q · filed 2021-05-14 | |
| 2019-09-30 | $39.80K 10-Q · filed 2021-05-14 | |
| 2019-06-30 | $169.00K 10-K · filed 2020-10-01 | |
| 2019-03-31 | $100.00K 10-Q · filed 2020-05-15 | |
| 2018-12-31 | $69.00K 10-Q · filed 2020-05-15 | |
| 2018-06-30 | $130.00K 10-K · filed 2019-10-15 | |
| 2018-03-31 | $139.93K 10-Q · filed 2019-05-15 | |
| 2017-09-30 | $39.84K 10-Q · filed 2019-05-15 | |
| 2017-06-30 | $459.94K 10-K · filed 2018-09-17 | |
| 2016-06-30 | -$822.30K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | $1.23M 10-K · filed 2017-09-28 |
| 2015-06-30 | $741.28K 10-K · filed 2016-09-28 | |
| 2014-06-30 | $244.50K 10-K · filed 2015-09-30 | |
| 2013-06-30 | $0.00 10-K · filed 2014-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |